BIOINDUSTRY · BIOCATALYSIS

Biocatalysis for APIs and intermediates

When an enzyme or a whole cell takes the place of a chemical step. This is the area where the catalyst is chosen, the reaction is designed, and it is decided whether the enzyme works free or immobilised.

Tell us about your reaction
THE PROBLEM IT SOLVES

A reaction that has to cost less, or pollute less

Biocatalysis is chosen for selectivity, for milder conditions or for a better environmental profile. But it only pays if the catalyst holds for the number of cycles the economics require — and that is what gets measured.

You have a chemical step to replace

Poor selectivity, harsh conditions, by-products to dispose of. It starts from feasibility: does an enzyme exist that performs that transformation, and under which conditions.

You have an enzyme that works once

In batch it is fine, but the cost of the biocatalyst per kilo of product does not add up. This is where immobilisation changes the economics of the reaction.

You have a reaction to take continuous

Flow or packed-bed reactor: it takes a suitable support, measured kinetics and operational stability over time.

The services in this area

Two services chosen in sequence: first the reaction, then the form the catalyst works in.

The biocatalytic steps with the greatest impact in pharma

What we measure

The numbers on which it is decided whether a biocatalytic route really replaces the chemical one.

  • Conversion and selectivity — how much substrate becomes product, and how much becomes something else
  • Enantiomeric excess — where chirality is the reason the enzyme was chosen in the first place
  • Specific activity — activity per unit of biocatalyst, free and immobilised
  • Number of cycles — how many times the immobilised catalyst is reused before it drops below threshold
  • Operational stability — residual activity over time, under real reaction conditions
  • Space-time yield — product per litre of reactor and per hour
  • Biocatalyst cost — per kilo of product, which is the number the decision rests on
  • Behaviour in flow — bed integrity and pressure drop, when the reaction goes continuous

Techno-economic assessment

The cost is worked out after screening, not at the end. With the first-stage data we calculate cost per kilogram against the process in use: biocatalyst and number of cycles, solvent and recovery, downstream separations, energy. It is done halfway through the investment, while there is still time to decide whether to go on. Every stage has go/no-go criteria stated before it starts.

Equipment for this area

ReactionThermostatted bioconversion reactors with pH and temperature control, and packed-bed flow trials
ImmobilisationDifferent supports and binding chemistries, with comparative screening of immobilisation conditions
AnalyticsPreparative HPLC and UPLC, GC with mass spectrometry and headspace, SEC, SDS-PAGE, spectrophotometers and titrators
ScreeningA.L.EX, the robotic platform for high throughput screening, up to 40,000 samples a day
Techniques in partnershipNMR with a qualified external partner, when structural confirmation is needed

Frequently asked questions

Where can a project start from?

From a target molecule, a chemical transformation, an existing process or an enzyme or microorganism already identified.

What does a project include?

Enzyme and microorganism screening, biocatalyst development, bioconversion optimisation, downstream and scale-up, with go/no-go criteria at every stage.

When does biocatalysis pay off?

When you need selectivity, milder conditions or less waste, and the biocatalyst lasts the cycles the economics require: we check it with a techno-economic assessment halfway through.

Let us talk about the step you want to replace

Tell us which chemical step it is and the constraints you work under: we will tell you whether an enzymatic route makes sense and how to check.

Tell us about your reaction

Tell us about your project

Write to us here: the division team will get back to you.